NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 Crisis

    NEXT STORY
    Rockwell Medical, Inc. Receives FDA Approval for Triferic® AVNU (Ferric Pyrophosphate Citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients
    PREV STORY
    VAXIL COMMENCES PRECLINICAL COVID-19 VACCINE TRIAL AND FILES AN ADDITIONAL COVID-19 PATENT
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Life Foundation Hosts 2016 “Run for Life” 5K to Support Those with Infertility

    CHICAGO, Sept. 07, 2016 (GLOBE NEWSWIRE) -- The Kevin J. Lederer Life Foundation will ...

    author_avatar
    NASDAQ Market News

    Trillium Therapeutics Announces Data Presentations at Upcoming Scientific Meetings

    Updated safety and efficacy data from the TTI-621 intravenous trial at the 16th Annual ...

    author_avatar
    NASDAQ Market News

    Central Maine Healthcare Selects R1 for Revenue Capture Solutions

    CHICAGO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider ...

    author_avatar
    NASDAQ Market News